Alex Goldberg

DARA BioSciences, Inc (NASDAQ:DARA) and Comcast Corporation (NASDAQ:CMCSK) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/17/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding DARA BioSciences, Inc (NASDAQ:DARA) and Comcast Corporation (NASDAQ:CMCSK).

DARA BioSciences, Inc (NASDAQ:DARA) a development stage biopharmaceutical company that engages in the development and commercialization of oncology treatment and supportive care pharmaceutical products in the United Sates closed up in its previous session (+18.00%) on 6,602,309 shares traded. DARA BioSciences, Inc (NASDAQ:DARA) is currently up (+26.67%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about DARA BioSciences, Inc (NASDAQ:DARA)

Comcast Corporation (NASDAQ:CMCSK) operates as a media and technology company worldwide closed up in its previous session (+0.06%) on 1,754,696 shares traded as Comcast is to Participate in Citigroup Investor Conference On Tuesday, January 7, 2014. Comcast Corporation (NASDAQ:CMCSK) is currently up (+37.57%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Comcast Corporation (NASDAQ:CMCSK)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com